Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer
Discover Oncology · 26.09.2025 · 16 (1)
DOI: 10.1007/s12672-025-03490-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 26.09.2025. Verfasst von Vinit Sharma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Science and Technology, Chandigarh Administration, India.
Abstract (Originalsprache)
AIM: Pancreatic cancer (PC) is marked by high mortality and resistance to conventional therapies, largely due to a dense desmoplastic stroma that promotes drug resistance and metastasis. This highlights the need for specific non-invasive diagnostic markers. MicroRNAs (miRNAs), known for regulating gene expression and influencing tumor behavior, have emerged as promising biomarkers. This study aimed to evaluate the expression of circulating miR-6875 and miR-1307 in PC patients to explore their diagnostic potential. METHODS: Blood, urine, and saliva samples were collected from 20 PC patients and 12 healthy controls. RNA extraction and cDNA synthesis were performed following standard protocols, and quantitative real-time PCR assays were used to quantify miR-6875 and miR-1307 expression levels. Statistical analysis was performed to predict their diagnostic potential and association with clinical and biochemical parameters of PC patients. RESULTS: Our results revealed significantly elevated levels of miR-6875 and miR-1307 in plasma, urine samples, and saliva samples from PC patients compared to controls. Receiver operating characteristic (ROC) curve analysis demonstrated the potential of miR-6875 and miR-1307 in plasma as diagnostic biomarkers for PC, with AUC values of 0.79 and 0.83, respectively. CONCLUSION: Plasma levels of miR-6875 and miR-1307 show potential as non-invasive diagnostic biomarkers for pancreatic cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India.
- Department of GI Surgery, HPB and Liver Transplantation, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
- Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, India. aggarwal.anjali@pgimer.edu.in.
ORCID-Profile: Vinit Sharma, Ankita Semwal, Shivangani Lohani, Ankita Arora, Sakshi Bansal, Mayank Sharma, Anjali Aggarwal
Förderung
- Department of Science and Technology, Chandigarh Administration, India
Zitieren
APA
Sharma, V., Semwal, A., Lohani, S., Arora, A., Bansal, S., Sharma, M., Gupta, R., Singh, H., & Aggarwal, A. (2025). Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03490-3
Vancouver
Sharma V, Semwal A, Lohani S, Arora A, Bansal S, Sharma M, et al. Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03490-3
BibTeX
@article{Sharma2025,
author = {Sharma, Vinit and Semwal, Ankita and Lohani, Shivangani and Arora, Ankita and Bansal, Sakshi and Sharma, Mayank and Gupta, Rajesh and Singh, Harjeet and Aggarwal, Anjali},
title = {Potential of circulating miR-6875 and miR-1307 as non-invasive diagnostic biomarkers for pancreatic cancer},
journal = {Discover Oncology},
year = {2025},
volume = {16},
number = {1},
doi = {10.1007/s12672-025-03490-3}
}
EUVIMED